Recheck four things: the current version of the plan’s drug list, whether an approved authorization is still inside its own end date, whether the dispensing pharmacy is still contracted, and where the year stands against the deductible. Exchange plans reset annually, and switching plans mid-year needs a qualifying life event.
Three clocks, and they are not the same clock
People treat coverage as one continuous state that is either on or off. It is actually several overlapping periods, and a prescription that filled in February and rejects in July has usually crossed a boundary in one of them.
The benefit year is the twelve-month period during which the deductible and out-of-pocket totals accumulate before resetting. The plan year is the period the contract itself covers, which for individual exchange coverage generally follows the calendar. And an authorization carries its own end date, set when it was granted, which can expire well before either of the others. Those three dates rarely coincide, so the useful question when something changes is not whether coverage lapsed but which period just turned over.
What can move while the year is running
A formulary is a living document. Products get added, dropped, or repositioned during a plan year, and a plan can also change which pharmacies it contracts with or route a drug class to a designated channel. Any of those produces a rejection that reads at the counter like a loss of coverage.
Where a drug moves or comes off, the exceptions route remains available for the rest of the year. The prescriber confirms to the plan that the requested drug fits the medical situation, on the grounds that covered alternatives have not worked or are not expected to, that an alternative caused or is likely to cause harmful side effects, or that a permitted dosage has not worked. Some plans also provide a one-time fill so treatment is not interrupted while that request is decided, which is worth asking about at the counter rather than after leaving it.
When a drug does come off mid-year, the pricing landscape outside the plan is worth learning before the next fill. It ranges from the makers’ own self-pay pharmacies to consumer services such as Ro, Hims and Hers and HealthRX, with HealthRX showing branded Wegovy at a listed self-pay rate rather than a compounded stand-in. The rate that belongs next to the old copay is the one for the branded medicine.
What cannot move while the year is running
The plan itself. Exchange enrollees change plans during the annual window or not at all, unless a qualifying life event opens a special enrollment period. Moving, marriage, a birth and losing other coverage are the familiar triggers, and each comes with a limited window rather than an open invitation. Discovering that a different issuer’s formulary would have been better is not a qualifying event, which is the single most expensive surprise in this category.
The annual reset
Open enrollment for exchange coverage runs from November 1 to January 15. That period is when the drug list attached to next year’s plans can be compared against the current one, when a different metal category can be chosen, and when income and household details on the application should be updated so any premium savings are calculated against the right year.
Coverage can renew without action, and that is where people get caught. A renewed plan is a newly filed plan. Its formulary, its network and its cost sharing are all set fresh for the coming year, so continuity of enrollment is not continuity of benefits. January is the month to check the drug list version, not the month to assume last year’s answer carried over.
| What to recheck | Where it lives | When it typically changes | What it breaks if missed |
|---|---|---|---|
| Drug list version | Issuer website, plan documents | Any time, and at renewal | Claim rejects as not covered |
| Authorization end date | The approval letter | On its own schedule | Fills stop with no notice |
| Pharmacy contract status | Issuer pharmacy locator | At renewal, sometimes mid-year | Claim rejects as out of network |
| Deductible progress | Member account, claims history | Resets each benefit year | January cost is far higher than December |
| Metal category and cost share | Summary of Benefits and Coverage | Only at open enrollment | Copay changes without the drug changing |
The January price shock that is not a coverage change
A common report is that the drug “stopped being covered” on the first of the year when in fact it is still on the list and the deductible has reset. Nothing was withdrawn. The accumulated total went back to zero, so the member is paying the pre-deductible amount again for the first stretch of the new year. Checking the member account before making calls separates this from a genuine formulary change, and the two require completely different responses.
When the drug genuinely comes off
If the list changed and an exception request fails, the cash market becomes the live comparison. Novo Nordisk and Eli Lilly run direct self-pay channels for their branded products, while supervised telehealth practices such as Ro, LifeMD, Hims and Hers and FormBlends post flat monthly figures covering the visit and the medication together. The two sets of prices describe different things: compounded preparations are not FDA-approved products and are not reviewed by the agency for safety, effectiveness or manufacturing quality. Worth noting alongside the price question is that stopping treatment has its own consequence, since trial extension data on semaglutide withdrawal recorded substantial regain of lost weight after discontinuation.
Questions people ask
Does the plan have to warn members before a formulary change?
Plans generally notify members affected by changes to a drug they are taking, and the notice is the trigger to start an exception request rather than to wait. Notices go to the address and email on the account, so an out-of-date contact record is a common reason the first warning arrives at the pharmacy counter.
Does an approval carry into the new plan year?
Not reliably. Authorizations carry an end date and the formulary is refiled annually, so an approval granted in autumn can expire or lose its basis in January. Asking the prescribing office to renew before the year turns avoids a gap that otherwise surfaces at the first fill of January.
What happens to coverage after a move to another state?
Exchange plans are sold within a state, so a move generally ends the fit and opens a special enrollment period. That window is limited and enrollment is not automatic. Since the new state’s plans follow a different benchmark, the drug list should be checked before choosing, not after.
Do payments made during a coverage gap count toward the deductible?
No. Only cost sharing on covered services accumulates toward the deductible and the out-of-pocket maximum. Amounts paid while a claim is rejected, or paid directly to a cash pharmacy or telehealth practice, sit outside the plan’s counters entirely and do not appear in the member account.
